For instance, cognitive symptoms of AD are improved by the inhibition of acetylcholinesterase (AChE) enzyme activity1 and by the modulation of N-methyl-D-aspartate glutamate receptor (NMDAR) signaling with the weak NMDAR antagonist memantine2. This evidence concerns the gene ACHE and Alzheimer disease.